Point-of-Care Glucose Testing Market Growth, Size, Trends Analysis - By Product - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Point-of-Care Glucose Testing Market Introduction and Overview

According to SPER market research, 'Global Point-of-Care Glucose Testing Market Size- By Product - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Point-of-Care Glucose Testing Market is predicted to reach 5.36 Billion by 2034 with a CAGR 4.39%.

The report includes an in-depth analysis of the Global Point-of-Care Glucose Testing Market, including market size and trends, product mix, Applications, and supplier analysis. The expanding geriatric population, the ability of point-of-care (POC) diagnostic tests to provide immediate results, leading to better patient care, and the growing use of electronic medical records (EMRs) are significant factors driving this market. Additionally, the shortage of skilled healthcare professionals, particularly in diagnostics, is expected to further boost the adoption of glucose POC diagnostic products.

Restraints: Strict regulatory approvals, necessary for safety and accuracy, create hurdles for point-of-care diagnostic product commercialization. These rigorous processes, including testing and trials mandated by bodies like the FDA and CE marking, result in delayed market entry, high development costs, and challenges for smaller businesses. Furthermore, the lack of standardization between point-of-care and lab testing, coupled with potential pre-analytical errors and testing performed by non-physicians, may restrict broader use of point-of-care diagnostics.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Abbott, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc. and others.

Point-of-Care Glucose Testing Market Segmentation:

By Product: Based on the Product, Global Point-of-Care Glucose Testing Market is segmented as; Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Other.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Product Code: HLCA2583

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Point-of-Care Glucose Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Point-of-Care Glucose Testing Market

7. Global Point-of-Care Glucose Testing Market, By Product, (USD Million) 2021-2034

7.1. Accu Check Aviva Meter
7.2. Onetouch Verio Flex
7.3. i-STAT
7.4. Bayer CONTOUR Blood Glucose Monitoring System
7.5. Freestyle Lite
7.6. True Metrix
7.7. Accu-Chek Inform II
7.8. StatStrip
7.9. Others

8. Global Point-of-Care Glucose Testing Market, (USD Million) 2021-2034

8.1. Global Point-of-Care Glucose Testing Market Size and Market Share

9. Global Point-of-Care Glucose Testing Market, By Region, (USD Million) 2021-2034

9.1. Asia-Pacific
- 9.1.1. Australia
- 9.1.2. China
- 9.1.3. India
- 9.1.4. Japan
- 9.1.5. South Korea
- 9.1.6. Rest of Asia-Pacific
9.2. Europe
- 9.2.1. France
- 9.2.2. Germany
- 9.2.3. Italy
- 9.2.4. Spain
- 9.2.5. United Kingdom
- 9.2.6. Rest of Europe
9.3. Middle East and Africa
- 9.3.1. Kingdom of Saudi Arabia
- 9.3.2. United Arab Emirates
- 9.3.3. Qatar
- 9.3.4. South Africa
- 9.3.5. Egypt
- 9.3.6. Morocco
- 9.3.7. Nigeria
- 9.3.8. Rest of Middle-East and Africa
9.4. North America
- 9.4.1. Canada
- 9.4.2. Mexico
- 9.4.3. United States
9.5. Latin America
- 9.5.1. Argentina
- 9.5.2. Brazil
- 9.5.3. Rest of Latin America

10. Company Profile

10.1. Abbott
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
10.2. ACON Laboratories
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
10.3. Bayer AG/Ascensia Diabetes Care Holdings AG
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
10.4. EKF Diagnostics
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
10.5. F. Hoffmann-La Roche Ltd.
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
10.6. Nipro
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
10.7. Nova Biomedical
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
10.8. PlatInium Equity Advisors, LLC (Lifescan, Inc.)
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
10.9. Prodigy Diabetes Care, LLC
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
10.10. Trividia Health, Inc.
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
10.11. Others